Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 85.9%

Neg 0% Neu 0% Pos 85.9%

Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $58 to $60.